Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical Supply
Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength). This recall is due to the detection of an impurity – N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) – found in six lots of active pharmaceutical ingredient (API) manufactured by Hetero Labs Limited that is above the US Food & Drug Administration’s interim acceptable exposure limit of 9.82 ppm. Based on the available information, the risk of developing cancer in a few patients following long-term use of the product cannot be ruled out.
Losartan Potassium is indicated for the treatment of hypertension, hypertensive patients with left ventricular hypertrophy, and nephropathy in Type 2 diabetic patients. The lots were sold exclusively to Golden State Medical Supply of Camarillo, California. Golden State Medical Supply packages this bulk product under its own label and distributes in retail bottles of 30, 90, and 1000 tablets.
To date, Teva has not received any reports of adverse events related to the lots being recalled.
No other Teva Losartan Potassium finished drug products have been identified, in the United States, containing API above the interim specification levels set for NMBA.
The affected Losartan Potassium tablets being recalled are described as:
- Losartan Potassium tablets, USP 25 mg, are light-green, film-coated, teardrop-shaped biconvex tablet with “LK 25” on one side and ">" on the other side.
- Losartan Potassium tablets, USP 100 mg, are dark green, film-coated, oval-shaped biconvex tablets with “LK100” on one side and ">" on the other side.
Teva promptly notified Golden State Medical Supply of the presence of the impurity in Hetero’s API and Teva will recall thirty-five (35) lots of bulk Losartan Potassium tablets sold to that company. The tablets, which have been packaged and sold by Golden State Medical Supply, will be recalled from their customers and patients. Distributors and retailers that have product being recalled should immediately stop distribution, quarantine all remaining product in their control, and return the recalled product per the instructions given to them by Golden State Medical Supply.
Patients taking Losartan Potassium tablets are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. The immediate risk of harm to a patient’s health is likely to be higher if the medicine is stopped abruptly without any alternative treatment. For full drug product information, please refer to the full prescribing information for Losartan Potassium tablets USP.
Customers and patients with medical-related questions, who wish to report an adverse event, or quality issues about the Teva products being recalled under the Golden State Medical Supply label should contact Teva Medical Information by phone at: 888-838-2872, option 3, then, option 4. Live calls are received Monday-Friday, 9:00AM-5:00PM Eastern Time with voicemail available 24 hours/day, 7 days/week or by email at druginfo@tevapharm.com.
Adverse reactions or other problems experienced with the use of these products should also be reported to the FDA's MedWatch Adverse Event Reporting program online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm.
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-1088.
Patient safety and product quality are critical to Teva. As always, Teva and Golden State Medical Supply will continue to partner with, and regularly update, all relevant stakeholders, including regulatory authorities, to resolve this situation.
Lots Under Voluntary Recall
The finished product lots that are included in this voluntary recall and listed below were sold by Teva in bulk containers. The tablets were repackaged for further distribution by Golden State Medical Supply under its product label. The bulk tablet lots were repackaged into 44 finished products lots for further distribution by Golden State Medical Supply under its product label.
| GSMS FG NDCs |
GSMS FG
|
GSMS FG
|
GSMS FG
|
|||||||||
| 60429-318-90 |
Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle |
GS014045 | 06/2019 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS014305 | 06/2019 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS014054 | 06/2019 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS014044 | 06/2019 | |||||||||
| 60429-316-10 | Losartan Potassium, Tablets, USP, 25 mg, 1,000 Count Bottle | GS014817 | 06/2019 | |||||||||
| 60429-316-90 | Losartan Potassium, Tablets, USP, 25 mg, 90 Count Bottle | GS015172 | 06/2019 | |||||||||
| 60429-316-10 | Losartan Potassium, Tablets, USP, 25 mg, 1,000 Count Bottle | GS015204 | 06/2019 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016338 | 12/2019 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016341 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016342 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016343 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016344 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016345 | 01/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS016535 | 01/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS016524 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016539 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016969 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS016973 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS017337 | 01/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017384 | 02/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017385 | 01/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017539 | 01/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017540 | 01/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017543 | 01/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017542 | 01/2020 | |||||||||
| 60429-318-10 | Losartan Potassium, Tablets, USP, 100 mg, 1,000 Count Bottle | GS018524 | 02/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017984 | 02/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017985 | 02/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS017986 | 02/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS018263 | 02/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS018264 | 02/2020 | |||||||||
| 60429-316-90 | Losartan Potassium, Tablets, USP, 25 mg, 90 Count Bottle | GS017634 | 02/2020 | |||||||||
| 60429-316-90 | Losartan Potassium, Tablets, USP, 25 mg, 90 Count Bottle | GS017653 | 02/2020 | |||||||||
| 60429-316-90 | Losartan Potassium, Tablets, USP, 25 mg, 90 Count Bottle | GS017980 | 02/2020 | |||||||||
| 60429-316-30 | Losartan Potassium, Tablets, USP, 25 mg, 30 Count Bottle | GS017981 | 02/2020 | |||||||||
| 60429-318-90 | Losartan Potassium, Tablets, USP, 100 mg, 90 Count Bottle | GS018265 | 02/2020 | |||||||||
| 60429-316-90 | Losartan Potassium, Tablets, USP, 25 mg, 90 Count Bottle | GS016726 | 02/2020 | |||||||||
| 60429-316-30 | Losartan Potassium, Tablets, USP, 25 mg, 30 Count Bottle | GS016958 | 02/2020 | |||||||||
| 60429-316-90 | Losartan Potassium, Tablets, USP, 25 mg, 90 Count Bottle | GS017045 | 02/2020 | |||||||||
| 60429-316-90 | Losartan Potassium, Tablets, USP, 25 mg, 90 Count Bottle | GS017276 | 02/2020 | |||||||||
| 60429-316-30 | Losartan Potassium, Tablets, USP, 25 mg, 30 Count Bottle | GS017341 | 02/2020 | |||||||||
| 60429-316-10 | Losartan Potassium, Tablets, USP, 25 mg, 1,000 Count Bottle | GS018318 | 02/2020 | |||||||||
| 60429-316-10 | Losartan Potassium, Tablets, USP, 25 mg, 1,000 Count Bottle | GS017342 | 02/2020 | |||||||||
| 60429-316-10 | Losartan Potassium, Tablets, USP, 25 mg, 1,000 Count Bottle | GS017808 | 02/2020 | |||||||||
Note – “GSMS FG” refers to Golden State Medical Supply Finished Goods.
Patients wishing to return product may contact Teva’s product recall processor to obtain instructions and a return kit for returning their medication:
- Contact Inmar at 877-789-2065 (Hours of operation: 9 am to 5 pm Eastern Time, Monday – Friday) or email Inmar at: tevarecalls@inmar.com.
- Inmar will provide the materials needed to return their medication and instructions for reimbursement.
-
Customers of Golden State Medical Supply may:
- Call: (800) 284-8633, ext. 215
- Fax: (805) 437-7582
- Email: recalls@gsms.us
Product labels associated with the lots being recalled will be posted to the FDA website under Recalls and Alerts.
Consumers
Teva’s Medical Information
druginfo@tevapharm.com
888-838-2872
Media:
Eric Rubin
973-265-3759
Kelley Dougherty
973-658-0237
